Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
22 09 2020
22 09 2020
Historique:
received:
08
05
2020
accepted:
07
08
2020
entrez:
16
9
2020
pubmed:
17
9
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
Primary effusion-based lymphoma (EBL) presents as a malignant effusion in a body cavity. The clinicopathologic features and prognosis of primary human herpesvirus 8 (HHV8)-negative EBL remain unclear. We therefore conducted a retrospective study of 95 patients with EBL, regardless of HHV8 status, in Japan. Of 69 patients with EBL tested for HHV8, a total of 64 were negative. The median age of patients with primary HHV8-negative EBL at diagnosis was 77 years (range, 57-98 years); all 58 tested patients were negative for HIV. Primary HHV8-negative EBL was most commonly diagnosed in pleural effusion (77%). Expression of at least 1 pan B-cell antigen (CD19, CD20, or CD79a) was observed in all cases. According to the Hans algorithm, 30 of the 38 evaluated patients had nongerminal center B-cell (non-GCB) tumors. Epstein-Barr virus-encoded small RNA was positive in 6 of 45 patients. In 56 of 64 HHV8-negative patients, systemic therapy was initiated within 3 months after diagnosis. Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) or CHOP-like regimens with or without rituximab (n = 48) were the most common primary treatments. The overall response and complete response rates were 95% and 73%, respectively. Three patients did not progress without systemic treatment for a median of 24 months. With a median 25-month follow-up, the 2-year overall survival and progression-free survival rates were 84.7% and 73.8%. Sixteen patients died; 12 were lymphoma-related deaths. Thus, most EBL cases in Japan are HHV8-negative and affect elderly patients. The non-GCB subtype is predominant. Overall, primary HHV8-negative EBL exhibits a favorable prognosis after anthracycline-based chemotherapy.
Identifiants
pubmed: 32936906
pii: S2473-9529(20)31526-3
doi: 10.1182/bloodadvances.2020002293
pmc: PMC7509864
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4442-4450Informations de copyright
© 2020 by The American Society of Hematology.
Références
Ann Hematol. 2003 Dec;82(12):773-6
pubmed: 14517692
Hum Pathol. 1997 Jan;28(1):101-4
pubmed: 9013840
J Virol. 2000 Apr;74(8):3478-85
pubmed: 10729121
World J Gastroenterol. 2014 Jan 21;20(3):857-62
pubmed: 24574759
Cancer Genet Cytogenet. 2005 Jan 1;156(1):49-53
pubmed: 15588855
Acta Haematol. 2007;117(3):132-44
pubmed: 17135726
Am J Surg Pathol. 1998 Dec;22(12):1528-37
pubmed: 9850179
Int J Hematol. 2004 Apr;79(3):271-5
pubmed: 15168597
APMIS. 2009 Mar;117(3):222-9
pubmed: 19245595
Blood. 1996 Jul 15;88(2):645-56
pubmed: 8695812
Int J Hematol. 2011 Sep;94(3):279-284
pubmed: 21858447
Acta Haematol. 2013;130(3):217-21
pubmed: 23816805
Int J Hematol. 2001 Oct;74(3):327-32
pubmed: 11721971
Clin Cancer Res. 2007 Sep 1;13(17):5124-32
pubmed: 17785567
Blood. 2015 Jan 1;125(1):22-32
pubmed: 25499448
Am J Hematol. 2004 May;76(1):88-91
pubmed: 15114607
Blood. 1997 Aug 1;90(3):1186-91
pubmed: 9242551
Leuk Lymphoma. 2005 Mar;46(3):415-9
pubmed: 15621832
Semin Cancer Biol. 1999 Jun;9(3):175-85
pubmed: 10343069
Am J Surg Pathol. 2003 Jan;27(1):16-26
pubmed: 12502924
Sci Rep. 2016 Mar 07;6:22730
pubmed: 26947392
Case Rep Oncol Med. 2014;2014:436821
pubmed: 24716045
Blood. 2018 Nov 1;132(18):1879-1888
pubmed: 30154110
Pathol Res Pract. 2015 Dec;211(12):1010-3
pubmed: 26384578
J Clin Oncol. 2011 Oct 10;29(29):e747-50
pubmed: 21810684
Clin Oncol (R Coll Radiol). 2005 Dec;17(8):636-8
pubmed: 16372490
Intern Med. 2008;47(24):2175-8
pubmed: 19075546
Leuk Lymphoma. 2003 Nov;44(11):2019-22
pubmed: 14738159
J Gen Fam Med. 2017 Mar 21;18(1):38-41
pubmed: 29263988
Ann Hematol. 2011 Feb;90(2):219-20
pubmed: 20432036
Int J Hematol. 2018 Sep;108(3):329-334
pubmed: 29516290
Hematol Oncol. 2017 Dec;35(4):878-883
pubmed: 27859456
Syst Rev. 2014 Feb 12;3:11
pubmed: 24521144
Leuk Lymphoma. 2003 Oct;44(10):1811-4
pubmed: 14692539
Lab Med. 2014 Spring;45(2):136-40
pubmed: 24868994
Haematologica. 2008 Jan;93(1):e21-3
pubmed: 18166773
Diagn Cytopathol. 2017 Mar;45(3):257-261
pubmed: 27888664
Histopathology. 2018 May;72(6):930-944
pubmed: 29206290
Intern Med. 2003 Apr;42(4):351-3
pubmed: 12729325
Tuberc Respir Dis (Seoul). 2012 Dec;73(6):336-41
pubmed: 23319997
Leuk Lymphoma. 2002 Mar;43(3):595-601
pubmed: 12002764
Am J Surg Pathol. 2013 Feb;37(2):241-9
pubmed: 23282971
Blood. 2019 Jan 24;133(4):377-380
pubmed: 30510084
BMJ Case Rep. 2012 Jul 13;2012:
pubmed: 22802562
N Engl J Med. 2002 Jan 24;346(4):235-42
pubmed: 11807147
Intern Med. 2004 Mar;43(3):236-42
pubmed: 15098608
Int J Hematol. 2009 Jul;90(1):94-98
pubmed: 19484335
J Clin Pathol. 2006 Nov;59(11):1221-2
pubmed: 17071811
N Engl J Med. 1995 May 4;332(18):1186-91
pubmed: 7700311
Intern Med. 2010;49(13):1303-6
pubmed: 20606364
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Eur J Haematol. 2003 Jul;71(1):62-7
pubmed: 12801300
Am J Hematol. 2010 Jan;85(1):85-7
pubmed: 20029949
J Med Virol. 1999 Feb;57(2):159-62
pubmed: 9892401
Respir Med Case Rep. 2015 Nov 23;16:169-71
pubmed: 26744692
Curr Top Microbiol Immunol. 2007;312:263-87
pubmed: 17089801
Am J Clin Pathol. 2013 Aug;140(2):258-73
pubmed: 23897264
J Res Med Sci. 2014 Feb;19(2):190-2
pubmed: 24778676
Am J Hematol. 2004 Dec;77(4):419-20
pubmed: 15551361
Ann Hematol. 2014 Sep;93(9):1609-10
pubmed: 24408158
Leuk Lymphoma. 2016 Jul;57(7):1625-32
pubmed: 26727336
Age Ageing. 2006 Jan;35(1):94-6
pubmed: 16364944
J Clin Exp Hematop. 2017;57(2):69-73
pubmed: 29021516
Cancer Res. 1971 Nov;31(11):1860-1
pubmed: 5121694
Cancer. 2016 Sep 1;122(17):2689-97
pubmed: 27337679
Leuk Lymphoma. 2001 Mar;41(1-2):185-9
pubmed: 11342372
Pathol Int. 2001 Apr;51(4):293-300
pubmed: 11350613
Case Rep Oncol Med. 2013;2013:292301
pubmed: 23401819
N Engl J Med. 1993 Sep 30;329(14):987-94
pubmed: 8141877
Medicine (Baltimore). 2017 Oct;96(43):e8010
pubmed: 29068981
Science. 1994 Dec 16;266(5192):1865-9
pubmed: 7997879